共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
Shirai M Hayakawa H Nakano Y Nakamura Y Fujita K Suda T Chida K 《Kekkaku : [Tuberculosis]》2006,81(4):345-349
A 31-year-old man was admitted to our hospital because of frequent diarrhea. Colonoscopy showed ring ulcers on the rectum and ascending colon and chest X-ray showed abnormal shadows which were diagnosed as tuberculosis by sputum PCR. He started treatment with isoniazid (INH), rifampicin (RFP), pyrazinamide (PZA) and streptomycin (SM), however, eruption and ileus were seen. Then, he was retreated with ciprofloxacin (CPFX), kanamycin sulfate (KM) and prednisolone (PSL). Subsequently, we added RFP and further added calcium para-aminosalicylate (PAS). All these treatment was effective, and he was discharged from the hospital. 相似文献
3.
4.
Hitoshi Ichikawa Hirotoshi Ebinuma Shinichirou Tada Keisuke Ojiro Yoshiyuki Yamagishi Nobuhiro Tsukada Emi Hongou Osamu Funae Rie Irie Hidetsugu Saito Toshifumi Hibi 《Clinical journal of gastroenterology》2009,2(4):315-319
Liver dysfunction is a common complication observed in patients with hyperthyroidism, however the dysfunction is always mild and obvious jaundice is rarely observed. We present the case of a 43-year-old man who suffered from hyperthyroidism complicated by severe jaundice. The jaundice likely occurred as a secondary consequence of cholestasis due to hyperthyroidism, since other causes such as drug-induced or autoimmune liver dysfunction were ruled out. Treatment with methimazole improved severe cholestatic jaundice in parallel with normalization of thyroid function. The mechanism of cholestasis as a secondary complication of hyperthyroidism has not been uncovered and there is no specific biochemical marker for cholestasis due to this hormonal disease at present. This case serves as a reminder that severe jaundice can be a manifestation of simple hyperthyroidism, and that administration of antithyroid drugs is an effective treatment for severe cholestatic jaundice in such cases. 相似文献
5.
Shigenori Ishikawa Shuichi Yano Kiryo Wakabayashi Yoshiyuki Tokuda Kanako Kobayashi Toshikazu Ikeda Hiroyasu Takeyama 《Nihon Kokyūki Gakkai zasshi》2008,46(8):660-666
A rare case of chronic obstructive pulmonary disease (COPD) with severe pulmonary hypertension (PH) was found in a 68-year-old man. COPD was diagnosed in his 50s, from which time he received home oxygen therapy. In January 2007, he was admitted due to progression of dyspnea. On admission to our hospital, arterial blood gas analysis showed severe hypoxemia. Moreover, echocardiographic findings demonstrated severe deviation of the interventricular septum toward the left ventricle, with right ventricular dilatation. Cardiac catheterization data demonstrated pulmonary arterial hypertension with a low cardiac output. Because severe PH is uncommon in patients with COPD and there was no apparent etiology of PH other than COPD, we thought this case was predominantly a pulmonary vascular disease such as idiopathic pulmonary arterial hypertension. Though we first treated this patient with bosentan, it was not effective. Therefore, he was treated with continuous infusion of epoprostenol. Epoprostenol administration along with bosentan resulted in decrease of BNP and right ventricular function improvement. We report a case of severe PH due to severe COPD treated with continuous administration of epoprostenol. 相似文献
6.
A male patient with benign recurrent cholestasis since age 2.5 yr developed unremitting cholestasis with incapacitating pruritus and hepatic fibrosis by age 21. He was tried on numerous medical therapies for pruritus with transient or no relief. He responded only temporarily to biweekly plasmapheresis, which was carried out for 4 yr. He underwent orthotopic liver transplantation at age 25 with immediate resolution of his pruritus. At age 30 he is a happy, asymptomatic, fully employed professional. 相似文献
7.
A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents 总被引:1,自引:0,他引:1
Matsubara T Hasegawa M Shiraishi M Hoffman HM Ichiyama T Tanaka T Ueda H Ishihara T Furukawa S 《Arthritis and rheumatism》2006,54(7):2314-2320
In this report we describe a case of severe chronic infantile neurologic, cutaneous, articular (CINCA) syndrome with a novel G307V cryopyrin mutation and all of the characteristic clinical and laboratory features of this autoinflammatory disease. There was no clear response to standard therapies, including human interleukin-1 (IL-1) receptor antagonist (anakinra) and soluble tumor necrosis factor receptor (etanercept). The patient finally had a partial clinical response (reduction in fever and irritability) and complete laboratory response (improved C-reactive protein and serum amyloid A levels) to humanized anti-IL-6 receptor antibody (MRA), but died from congestive heart failure and interstitial pneumonia 2 months after initiation of therapy. We serially measured the serum cytokine levels and expression of NF-kappaB activation in the patient's peripheral blood mononuclear cells before and during consecutive therapies. Pathologic examination of autopsy specimens was also performed. This case illustrates the continued difficulty in management of patients with CINCA syndrome and the complexity of the inflammatory pathways in this disorder. 相似文献
8.
1临床资料
患者男,72岁,因阵发心前区疼痛20年,活动后气短不能平卧3年,加重7d入院。患者20年来阵发心前区疼痛,5年前疼痛呈持续性伴大汗,诊为急性下、正后壁心肌梗死。4年前冠状动脉造影示三支病变,行冠状动脉旁路移植术。3年前出现活动后气短,呼吸困难,不能平卧,伴腹胀,双下肢水肿,7d来加重再次入院。既往有高血压史30年,糖尿病史5年。2年前心电图出现左束支传导阻滞。查体:血压130/80mmHg,脉搏120次/min。颈静脉怒张,两肺底可闻及细湿哕音。心界扩大,心率120次/min,可闻及早搏及舒张期奔马律。肝肋下3cm可触及,双下肢指凹性浮肿。诊断缺血性心肌病,陈旧下壁、正后壁心肌梗死,心功能Ⅳ级,冠状动脉旁路移植术后,2型糖尿病,高血压病。入院后给予利尿剂、洋地黄、硝酸酯制剂及血管紧张素转换酶抑制剂等药物治疗,呼吸困难减轻.[第一段] 相似文献
9.
A case of Reiter's disease with severe skin manifestations successfully treated with oral etretinate 总被引:1,自引:0,他引:1
H Umehara S Kumagai S Kashii K Nagaoka T Hoshino H Imura 《Ryūmachi》1990,30(5):369-73, 374; discussion 373-4
A case of Reiter's syndrome with severe keratoderma being successfully treated with oral Etretinate is reported. A 38 year-old man was referred to our hospital in December, 1985 for treatment of refractory skin eruptions and polyarthralgia. He previously experienced urethritis in December, 1983 with subsequent development of high fever, balanitis, skin eruptions and polyarthritis. Treatments with antibiotics, anti-inflammatory drugs and glucocorticoids were ineffective at that time. The patient was diagnosed as Reiter's syndrome based on his clinical symptoms and the presence of HLA-B27. He was treated in our clinic with oral administration of Etretinate, aromatic retinoids, at the initial doses of 40 mg/day with subsequent increase up to 75 mg/day in 2 weeks. This maintenance dose was continued for two months, resulted in improvements of joint pain, skin eruptions and the laboratory abnormalities. The doses of Etretinate was gradually decreased and then was discontinued after 4 months, when approximately 90% of the skin lesion disappeared. No noticeable side-effect was observed except slight stomatitis. The remission continued for about 2 and half years after cessation of Etretinate without any medication. However, evidence of relapse with the same skin lesions and arthralgia was observed in March, 1989. A repeated treatment with oral Etretinate was attempted with similar but slightly delayed effects. 相似文献
10.
11.
Izumi T Shimizu E Imakiire T Kikuchi Y Oshima S Kubota T Hakozaki Y 《Internal medicine (Tokyo, Japan)》2010,49(21):2321-2326
A 48-year-old Japanese male was admitted to our hospital due to hyperosmolar hyperglycemic state (HHS), combined with rhabdomyolysis and acute kidney injury. His blood sugar levels were gradually decreased by fluid resuscitation and insulin infusion; however, his renal function worsened, and he developed bloody stools. He required continuous hemodiafiltration to improve his hemodynamics. As colonoscopy revealed longitudinal ulcers, ischemic colitis was diagnosed. We treated him conservatively at first, but when we found the ulceration of the sigmoid colon had penetrated the mesenterium, colectomy was indicated. After surgery, his general condition improved. Careful monitoring of complications related to HHS is important. 相似文献
12.
13.
14.
Akihiro Yokoyama Motohiro Sekino Taiga Ichinomiya Hironori Ishizaki Keiko Ogami-Takamura Takashi Egashira Rintaro Yano Sojiro Matsumoto Ushio Higashijima Tetsuya Hara 《Medicine》2021,100(35)
Rationale:We present the first case of a patient with severe aortic stenosis who developed anaphylactic shock and was successfully treated with adrenaline and landiolol, a highly selective β1-receptor blocker, to prevent disruption of the myocardial oxygen supply–demand balance caused by tachycardia.Patient concerns:An 86-year-old woman was scheduled for simultaneous anterior–posterior fixation for a burst fracture of the 12th thoracic vertebra; 200 mg sugammadex, a neuromuscular blocking agent antagonist, was administered postoperatively, and she was extubated without complications. However, 6 min after extubation, her blood pressure decreased abruptly to 55/29 mm Hg, and her heart rate increased to 78 bpm. Then, we intervened with fluid loading, an increased dose of noradrenaline, and phenylephrine administration. However, her blood pressure did not increase.Diagnoses:A general observation revealed urticaria on the lower leg; thus, we suspected anaphylactic shock due to sugammadex administration.Interventions:We carefully administered 2 doses of 0.05 mg adrenaline and simultaneously administered landiolol at 60 μg/kg/min to suppress adrenaline-induced tachycardia. Adrenaline administration resulted in a rapid increase in blood pressure to 103/66 mm Hg and a maximum heart rate of 100 bpm, suppressing excessive tachycardia.Outcomes:The patient''s general condition was stable after the intervention, and circulatory agonists could be discontinued the following day. She was discharged from the intensive care unit on the fourth postoperative day.Lessons:Landiolol may help control the heart rate of patients with aortic stenosis and anaphylactic shock. The combined use of landiolol and adrenaline may improve patient outcomes; however, their efficacy and risks must be evaluated by studying additional cases. 相似文献
15.
16.
17.
Asymptomatic hyperuricemia: the case for conservative management 总被引:1,自引:0,他引:1
The management of asymptomatic hyperuricemia is controversial. Reported benefits from treatment prevention of acute gouty arthritis, chronic tophaceous gout, urolithiasis, or gouty nephropathy. A review of experimental and clinical data suggests that the risks of asymptomatic hyperuricemia are small or unknown and the efficacy of long-term treatment in preventing gout or renal disease is unproved. The costs and risks of prolonged drug administration and practical considerations such as patient compliance mitigate against long-term therapy in asymptomatic persons. We offer some recommendations for an expectant approach to the management of asymptomatic hyperuricemia. 相似文献
18.
M Arai H Kawada T Kaburagi N Sakai Y Kudou M Kawakami K Konno T Takizawa 《Nihon Kyōbu Shikkan Gakkai zasshi》1991,29(11):1457-1463
A 40-year-old man who lived in a wooden house built 30 years ago presented with complaints of fever, dry cough and dyspnea. Chest X-ray findings showed interstitial shadows throughout bilateral lung fields. After admission, high-dose administration of 3000 mg of methylprednisolone was performed because of deterioration of chest X-ray shadows and symptoms. In a week, clinical data and symptoms improved. Findings of BAL fluid on admission revealed a relative increase of lymphocytes, neutrophils and mast cells, and pathological findings of transbronchial lung biopsy revealed non-caseous granulation and alveolitis. Precipitating antibodies and indirect fluorescent antibodies against Trichosporon cutaneum and Cryptococcus neoformans had positive reactions and T. cutaneum was isolated and identified from the patient's house. A diagnosis of summer-type hypersensitivity pneumonitis was made according to the criteria advocated by Ando et al. This seemed to be a rare case of summer-type hypersensitivity pneumonitis prolonged after isolation from his normal living environment, successfully treated by high-dose administration of steroid. 相似文献
19.
Mizuno Y Fujimoto H Yokota K Kato Y Genka I Kanagawa S Kawana A Oka S Kimura S Kudo K Kano S 《Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases》2006,80(6):706-710
We report a 54-year-old Japanese man who contracted severe falciparum malaria after visiting West African countries. The patient presented with Plasmodium falciparum parasitemia of 10% on admission and was successfully treated with intravenous artesunate combined with continuous hemodiafiltration. We found that intravenous artesunate had excellent antimalarial activity with rapid parasite clearance and that few adverse effects were observed compared to those reported for intravenous quinine treatment. Supportive therapy was indispensable for saving the life of the patient. Few cases of intravenous artesunate treatment are reported in Japan because the drug has not been legally registered. We wish to emphasize the efficacy of intravenous artesunate with general supportive therapy in the treatment of possible imported severe malaria patients in Japanese medical settings. 相似文献